Importantly, various correlation analyses presented here may indicate that elevated APO-TCN2 was associated with a favorable B lymphocyte (73, 74) proteomic profile likely necessary for potent immune cell recruitment and TLS-formation (75) to drive antibody-mediated anti-tumor immune responses in the OSA patients examined. Here, TCN2 is linked to neoplasm.